Neurodevelopmental Pediatric Follow-Up After the Azithromycin Prevention in Labor Use Study.
Manimaran Ramani, Waldemar A Carlo, Musaku Mwenechanya et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial evaluated the impact of a single 2 g dose of intrapartum azithromycin on neurodevelopmental outcomes in children born with birth asphyxia. Conducted across six sites in five countries, the study found no significant differences in cognitive, language, or motor scores at 24 months between the azithromycin group and the placebo group, with a Cognitive Composite Score of 90.9±11.2 vs 90.9±11.7.
Key findings
- Cognitive Composite Score at 24 months was 90.9±11.2 for azithromycin vs 90.9±11.7 for placebo.
- No significant differences in Language Composite Score or Motor Composite Score between treatment groups.
- Subgroup analysis showed no differences in outcomes between regions of sub-Saharan Africa and South Asia.
Why it matters
Understanding the effectiveness of interventions during labor for neonates at risk of asphyxia is crucial for improving long-term developmental outcomes. This study suggests that azithromycin may not provide the anticipated benefits.